Trade Delcath Systems, Inc. - DCTH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.56 |
| Open | 5.49 |
| 1-Year Change | -7.58% |
| Day's Range | 5.44 - 5.52 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2024 | 5.56 | 0.17 | 3.15% | 5.39 | 5.67 | 5.33 |
| Apr 22, 2024 | 5.48 | 0.68 | 14.17% | 4.80 | 5.48 | 4.79 |
| Apr 19, 2024 | 4.85 | 0.20 | 4.30% | 4.65 | 4.86 | 4.57 |
| Apr 18, 2024 | 4.67 | 0.31 | 7.11% | 4.36 | 4.98 | 4.24 |
| Apr 17, 2024 | 4.45 | -0.19 | -4.09% | 4.64 | 4.74 | 4.42 |
| Apr 16, 2024 | 4.70 | -0.05 | -1.05% | 4.75 | 4.82 | 4.63 |
| Apr 15, 2024 | 4.82 | -0.04 | -0.82% | 4.86 | 4.97 | 4.69 |
| Apr 12, 2024 | 4.93 | -0.02 | -0.40% | 4.95 | 4.97 | 4.81 |
| Apr 11, 2024 | 4.98 | 0.05 | 1.01% | 4.93 | 5.05 | 4.88 |
| Apr 10, 2024 | 4.97 | 0.08 | 1.64% | 4.89 | 5.00 | 4.83 |
| Apr 9, 2024 | 4.96 | -0.03 | -0.60% | 4.99 | 5.04 | 4.87 |
| Apr 8, 2024 | 5.01 | 0.07 | 1.42% | 4.94 | 5.31 | 4.94 |
| Apr 5, 2024 | 4.97 | 0.12 | 2.47% | 4.85 | 5.08 | 4.85 |
| Apr 4, 2024 | 5.00 | 0.17 | 3.52% | 4.83 | 5.07 | 4.83 |
| Apr 3, 2024 | 4.83 | 0.19 | 4.09% | 4.64 | 4.88 | 4.64 |
| Apr 2, 2024 | 4.67 | -0.11 | -2.30% | 4.78 | 4.79 | 4.59 |
| Apr 1, 2024 | 4.77 | 0.02 | 0.42% | 4.75 | 4.99 | 4.74 |
| Mar 28, 2024 | 4.76 | -0.24 | -4.80% | 5.00 | 5.00 | 4.74 |
| Mar 27, 2024 | 5.06 | 0.37 | 7.89% | 4.69 | 5.13 | 4.52 |
| Mar 26, 2024 | 4.59 | 0.04 | 0.88% | 4.55 | 4.72 | 4.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Delcath Systems, Inc. Company profile
About Delcath Systems Inc
Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.
Equity composition
Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.
| Industry: | Medical Prosthetics |
1633 Broadway Ste 22C
NEW YORK
NEW YORK 10019-6708
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com